Provided by:
Neuroendocrine Tumor Board
2015
Neuroendocrine Tumor Board Meeting
Friday, November 6, 2015
7:30 am – 9:00 am
PCAM Ground Floor Radiology Conference Room
Moderators:
Debbie Cohen, MD – David Metz, MD
University of Pennsylvania
Target Audience
This program has been designed for departmental/institutional faculty, fellows, nurses, and allied health professionals in
the medical specialties of medicine, renal, gastroenterology, surgery, nuclear medicine, medical oncology, radiation
oncology, endocrine and medical genetics.
Educational Objectives
After completing this activity, participants should be able to:
 Provide state of the art treatments to patients with neuroendocrine tumors
 Coordinate care for management of neuroendocrine patients through a multidisciplinary approach
 Increase knowledge in complex genetic mutations of neuroendocrine patients and refer them appropriately for
genetic testing
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1.50
AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Approved for (PSRM) patient safety/risk management designation
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Bonita Bennett, RN
215-349-5562
Bonita.bennett@uphs.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial
interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this
purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in
CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all
content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to
contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were
instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of
CME and the peer reviewer Zalman Agus, MD, have disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to
the content of this educational activity:
PLANNING COMMITTEE MEMBER & SPEAKER NAME
DEBBIE COHEN, MD
PRESENTER NAME
KEITH A. CENGEL
NEVENA DAMJANOV, MD
Brooke Levenseller
ELIZABETH FOX
Ursina Teitelbaum, MD
NANJA SMALLS
Kristen Dilzell
KATIE FANSLAU
Katherine Nathanson, MD ROBERT ROSES, MD
The following individuals have reported the listed relevant financial relationships with commercial interests related to
the content of this educational activity.
PLANNING COMMITTEE MEMBER & PRESENTER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
David Metz, MD
AAA & Lexicon
PI Grant
Bonita Bennett, RN
Ipsen & Lexicon
Nursing Advisory Board
PRESENTER NAME
Arturo Loaiza-Bonilla, MD
Daniel Pryma, MD
Michael C. Soulen, MD
NAME OF COMMERCIAL INTEREST
Massive Bio, LLC
Progenics
Guerbet, LLC, BTG
Sirtex Medical
Merit Medical
RELATIONSHIP
Consultant
Research
Consultant/Research Support
Speaker/Proctor
Research
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property
rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial
benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research),
consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is
received or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
DAVID METZ, MD
MICHAEL C. SOULEN, MD
PRODUCT
PRRT & PROMID
VARIOUS CHEMOTHERAPEUTICS
Y-90 MICROSPHERES
INVESTIGATIONAL AND/OR OFF-LABEL USE
OFF-LABEL DISCUSSION
OFF LABEL INTRAARTERIAL DELIVERY
OFF LABEL